Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Phio Pharmaceuticals Corp. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 164.7K | 188.5K | +23.8K (+14.4%) |
| Value | $387.4K | $467.4K | +$80.1K (+20.7%) |
New holders (3)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 413 | $1.02K | 0.00% |
| Tower Research Capital LLC (TRC) | 406 | $1.01K | 0.00% |
| UBS Group AG | 13 | $32 | 0.00% |
Sold out (3)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 14,298 | $34.0K |
| Royal Bank of Canada | 3,464 | $8.00K |
| Mount Yale Investment Advisors, LLC | 27 | $63 |